tm
Seeing Is Believing
tm
Seeing Is Believing
MDNA is currently covered by 2 analysts with an average price target of $5.41. This is a potential upside of $5.1 (1645.16%) from yesterday's end of day stock price of $0.31.
Medicenna Therapeutics Corp's activity chart (see below) currently has 8 price targets and 10 ratings on display. The stock rating distribution of MDNA is 100% BUY.
Highest price target for MDNA is $1, Lowest price target is $1, average price target is $2.5.
Most recent stock forecast was given by MATTHEW BIEGLER from OPPENHEIMER on 14-Aug-2023. First documented stock forecast 10-Sep-2020.
Currently out of the existing stock ratings of MDNA, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 10 months 3 days ago
(14-Aug-2023)
0/1 (0%)
$8.2 (215.79%)
Buy
$2.5
$2.19 (706.45%)
$2.5
1 years 11 months 20 days ago
(28-Jun-2023)
0/7 (0%)
$2 (400.00%)
What is MDNA (Medicenna Therapeutics Corp) average time for price targets to be met?
Which analyst has the current highest performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?
Which analyst has the current lower performing score on MDNA (Medicenna Therapeutics Corp) with a proven track record?
Which analyst has the most public recommendations on MDNA (Medicenna Therapeutics Corp)?
Which analyst is the currently most bullish on MDNA (Medicenna Therapeutics Corp)?
Which analyst is the currently most reserved on MDNA (Medicenna Therapeutics Corp)?
